Gynecologic brachytherapy I: Proper incorporation of brachytherapy into the current multimodality management of carcinoma of the cervix

Seminars in Radiation Oncology

Volumn 12, Issue 1, 2002, Pages 40-52

  Nori, Dattatreyudu ^a,b   Dasari, Neeraja ^a   Allbright, Robert M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Department of Radiation Oncology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA;

BRACHYTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0036150168     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2002.28664     Document Type: Article

References (84)

1. Cancer statistics 2000
2. Prevalence of human papillomavirus in cervical cancer: A world wide perspective
3. Epidemiology of cervical cancer
4. The epidemiology of human papilloma virus infection in relation to cervical cancer
5. Problems with the clinical staging of carcinoma of the cervix
6. Radiotherapy alone in carcinoma of the intact uterine cervix according to G H Fletcher guidelines: A French cooperative study of 1383 cases
7. A reappraisal of the International Federation of Gynecology and Obstetrics staging system for cervical cancer. A study of patterns of care
8. Staging announcement. FIGO staging of gynecologic cancers; Cervical and vulva
9. The impact of lymph node status on survival in cervical carcinoma
10. Radiation therapy alone in the treatment of carcinoma of uterine cervix. I. Analysis of tumor recurrence
11. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of intact uterine cervix
12. Prospective surgical pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
13. The effect of volume of disease in patients with carcinoma of the uterine cervix
14. Prognostic value of c-myc protooncogene overexpression in early invasive carcinoma of the cervix
15. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients
16. Prognostic indices in gynecologic cancer
17. Adenocarcinoma of the uterine cervix: Prognosis and patterns of failure in 367 cases
18. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncologic Group study
19. Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer?
20. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix
21. Prognostic flow cytometric information in cervical squamous cell carcinoma: A multivariate analysis of 307 patients
22. DNA ploidy analysis of effectiveness of radiation therapy for cervical carcinoma
23. Patterns and sites of failure in cervix cancer treated in the USA in 1978
24. Prognostic and treatment factors affecting pelvic control of stage Ib and IIa-b carcinoma of the intact uterine cervix treated with radiation therapy alone
25. The effect of treatment duration on local control of squamous carcinoma of the tonsil and cervix
26. Stage IIB carcinoma of the cervix managed with radiation therapy: An analysis of prognostic factors
27. The effect of treatment duration in the local control of cervix cancer
28. Analysis of results of radiation therapy for stage Ib carcinoma of the cervix
29. Cervical cancer: Women aged 35 and younger compared to women aged 36 and older
30. Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariate analysis of the effect of age, stage, histology, and blood counts on survival
31. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients
32. The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix
33. No prognostic impact of flow-cytometric measured DNA ploidy and Sphase fraction in cancer of the uterine cervix: A prospective study of 465 patients
34. Human papillomavirus genotype as a major determinant of the course of cervical cancer
35. The human papillomavirus status of invasive cervical adenocarcinoma: A clinicopathological and outcome analysis
36. Tumor recurrence and survival in stage IB cancer of the cervix
37. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy
38. Radiation alone in the treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship
39. Carcinoma of the cervix treated by external irradiation alone
40. The patterns of care outcome study for cancer of the uterine cervix. Results of the second national practice survey
41. Patterns of care outcome studies. Results of the national practice in cancer of the cervix
42. Carcinoma of the uterine cervix treated by irradiation alone. Results of treatment at the National Cancer Center, Tokyo
43. Radiotherapy alone for medically inoperable carcinoma of the cervix: Stage IA and carcinoma in situ
44. Radical hysterectomy and pelvic lymphadenectomy for stage IB carcinoma of the cervix: 21 Years experience
45. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical carcinoma: A clinical review of 954 cases
46. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix
47. Radiation therapy alone in the treatment of carcinoma of the cervix: A 20 year experience
48. Carcinoma of the cervix: Analysis of bladder and rectal radiation dose and complications
49. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies
50. Presentation of therapeutic results in carcinoma of the female pelvis: Experience of the annual report on the results of treatment in carcinoma of the uterus, vagina and ovary
51. Cancer of the uterine cervix: Janeway lecture
52. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix
53. Radiation therapy alone or combined with surgery in the treatment of barrell shaped carcinoma of the uterine cervix (stages IB, IIA, IIB)
54. Clinical studies with adjunctive surgery and irradiation in the treatment of carcinoma of the cervix
55. Stage IB or IIA-B carcinoma of the uterine cervix greater than or equal to 6 cm in diameter. Is adjuvant extrafascial hysterectomy beneficial?
56. Bulky endocervical carcinoma: 23 Year experience
57. The American Brachytherapy Society recommendations for high-doserate brachytherapy for carcinoma of the cervix
58. Combined low-dose-rate brachytherapy and external beam radiation for cervical cancer: Experience over ten years
59. Multifractionated high-dose-rate brachytherapy with concomitant daily teletherapy for cervical cancer
60. A comparision of the efficacy and complication rates of low-dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma
61. High-dose rate and low-dose rate intracavitary therapy of the uterine cervix. Final results of Osaka University Hospital
62. High-doserate versus low-dose-rate brachytherapy in the treatment of cervical cancer: Analysis of tumor recurrence - The University of Wisconsin experience
63. Low dose rate vs high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: A clinical trial
64. Comparision of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation
65. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading radiotherapy with high-dose rate: A comparitive study with a low-dose rate system
66. Randomized comparision of flourouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes. A gynecologic Oncology Group and Southwest Oncology Group Study
67. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
68. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
69. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer
70. Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer
71. A dosage system for use in the treatment of cancer of the uterine cervix
72. Treatment of cancer of the cervix uteri: A revised "Manchester" method
73. A simple computer program for optimization of source loading in cervical intracavitary applicators
74. Intracavitary radiation treatment planning and dose evaluation
75. Intracavitary irradiation of carcinomas of the uterus and cervix: The Creteil method
76. Parametrial implant in stage IIIb cancer of the cervix: A five year study
77. Treatment of stage IIIb carcinoma of the cervix: Improvement in local control by radium needle implant to supplement the dose to the parametrium
78. Treatment of advanced cancer of the cervix with transperineal interstitial irradiation
79. Interstitial parametrial implant in carcinoma of the cervix stage IIB
80. Parametrial interstitial brachytherapy for advanced or recurrent pelvic malignancy: The Harvard/Stanford experience
81. A comparison of intracavitary versus interstitial irradiation in the treatment of cervical cancer